We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$82.7M
2
PEP icon
PepsiCo
PEP
+$76.8M
3
MAR icon
Marriott International
MAR
+$64.8M
4
TSN icon
Tyson Foods
TSN
+$62.8M
5
PARA
Paramount Global Class B
PARA
+$52.9M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BV
2326
DELISTED
Bazaarvoice, Inc.
BV
– –
-74,856
Closed -$300K
RT
2327
DELISTED
Ruby Tuesday Georgia
RT
$0 ﹤0.01%
225
– –
VWR
2328
DELISTED
VWR Corporation
VWR
– –
-54
Closed -$1K
FNFV
2329
DELISTED
Fidelity Natl Financial, Inc.
FNFV
– –
-21
Closed –
ATW
2330
DELISTED
Atwood Oceanics
ATW
$0 ﹤0.01%
86
– –
AMRI
2331
DELISTED
Albany Molecular Research Inc
AMRI
$0 ﹤0.01%
17
-80
-82% -$1.19K
CST
2332
DELISTED
CST Brands, Inc.
CST
$0 ﹤0.01%
15
-108
-88% -$4.97K
EXAR
2333
DELISTED
Exar Corporation
EXAR
$0 ﹤0.01%
+105
New +$916
TSL
2334
DELISTED
Trina Solar Limited
TSL
$0 ﹤0.01%
80
– –
ELNK
2335
DELISTED
EarthLink Holdings Corp.
ELNK
– –
-233
Closed -$1K
IQNT
2336
DELISTED
Inteliquent, Inc.
IQNT
– –
-13,844
Closed -$275K
APOL
2337
DELISTED
Apollo Education Group Inc Class A
APOL
$0 ﹤0.01%
+105
New +$913
TUBE
2338
DELISTED
TubeMogul, Inc.
TUBE
$0 ﹤0.01%
+94
New +$949
EOCA
2339
DELISTED
Endesa Americas S.A.
EOCA
$0 ﹤0.01%
62
– –
CVT
2340
DELISTED
CVENT, INC.
CVT
– –
-176
Closed -$6K
CPHD
2341
DELISTED
Cepheid Inc
CPHD
– –
-1,333
Closed -$40K
TLOG
2342
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$0 ﹤0.01%
3,925
– –
PVCT
2343
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$0 ﹤0.01%
5,000
– –
COSI
2344
DELISTED
COSI INC NEW COM STK (DE)
COSI
$0 ﹤0.01%
155
– –
OUTR
2345
DELISTED
OUTERWALL INC
OUTR
– –
-86
Closed -$3K
FEIC
2346
DELISTED
FEI COMPANY
FEIC
– –
-23
Closed -$2K
DANG
2347
DELISTED
E-COMMERCE CHINA DANGDANG INC SPNSRD ADS REP COM CL A (CYM)
DANG
– –
-105
Closed –
EMC
2348
DELISTED
EMC CORPORATION
EMC
– –
-368,441
Closed -$10M
AXLL
2349
DELISTED
AXIALL CORP COM STK (DE)
AXLL
– –
-84
Closed -$2K
SGNT
2350
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
– –
-198
Closed -$2K
92 93
94
95 96

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.